121 related articles for article (PubMed ID: 17602156)
1. Effects of sulodexide on hemostatic factors, lipid profile, and inflammation in chronic peritoneal dialysis patients.
Kim SB; Kim SH; Lee MS; Chang JW; Lee SK; Park JS
Perit Dial Int; 2007; 27(4):456-60. PubMed ID: 17602156
[TBL] [Abstract][Full Text] [Related]
2. Effects of Ginkgo biloba on haemostatic factors and inflammation in chronic peritoneal dialysis patients.
Kim SH; Lee EK; Chang JW; Min WK; Chi HS; Kim SB
Phytother Res; 2005 Jun; 19(6):546-8. PubMed ID: 16114087
[TBL] [Abstract][Full Text] [Related]
3. Effects of fixed low-dose warfarin on hemostatic factors in continuous ambulatory peritoneal dialysis patients.
Kim SB; Lee SK; Park JS; Chi HS; Hong CD; Yang WS
Am J Kidney Dis; 2001 Feb; 37(2):343-7. PubMed ID: 11157376
[TBL] [Abstract][Full Text] [Related]
4. Secretory activity of the coronary artery endothelial cells in conditions of the peritoneal dialysis.
Misian M; Baum E; Bręborowicz A
Ren Fail; 2022 Dec; 44(1):54-61. PubMed ID: 35174782
[TBL] [Abstract][Full Text] [Related]
5. Effects of beraprost sodium, an oral prostaglandin i2 analog, on hemostatic factors and inflammation in chronic peritoneal dialysis patients.
Kim KM; Kim HW; Lee JH; Chang JW; Park JS; Kim SB
Perit Dial Int; 2009; 29(2):178-81. PubMed ID: 19293355
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive study on hemostasis in CAPD patients treated with erythropoietin.
Malyszko J; Suchowierska E; Malyszko JS; Mysliwiec M
Perit Dial Int; 2002; 22(5):582-92. PubMed ID: 12455569
[TBL] [Abstract][Full Text] [Related]
7. [Acute effects of sulodexide on the lipid profile and on antithrombin III in patients with chronic renal insufficiency in hemodialysis treatment].
Averna MR; Citarella P; Picone F; Capodicasa G; Galione A; Rini G; Notarbartolo A
Clin Ter; 1984 Jan; 108(2):111-4. PubMed ID: 6232045
[No Abstract] [Full Text] [Related]
8. Sulodexide modulates the dialysate effect on the peritoneal mesothelium.
Misian M; Baum E; Breborowicz A
J Physiol Pharmacol; 2019 Dec; 70(6):. PubMed ID: 32203941
[TBL] [Abstract][Full Text] [Related]
9. Lack of effects of low-dose aspirin on high-sensitivity C-reactive protein, hemostatic factors, and troponin T in CAPD patients.
Kim SB; Lee SK; Min WK; Chi HS; Park JS
Perit Dial Int; 2002; 22(6):721-3. PubMed ID: 12556076
[No Abstract] [Full Text] [Related]
10. Endothelial cell injury markers in chronic renal failure on conservative treatment and continuous ambulatory peritoneal dialysis.
Małyszko J; Małyszko JS; Myśliwiec M
Kidney Blood Press Res; 2004; 27(2):71-7. PubMed ID: 14691349
[TBL] [Abstract][Full Text] [Related]
11. Effect of peritoneal dialysis solution type on serum lipid levels in end-stage renal disease.
Kanbay M; Bavbek N; Delibasi T; Koca C; Kaya A; Altay M; Akcay A; Duranay M; Yigitoglu R
Ren Fail; 2007; 29(3):309-13. PubMed ID: 17497445
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological actions of sulodexide.
Ofosu FA
Semin Thromb Hemost; 1998; 24(2):127-38. PubMed ID: 9579633
[TBL] [Abstract][Full Text] [Related]
13. Additive thrombin inhibition by fast moving heparin and dermatan sulfate explains the anticoagulant effect of sulodexide, a natural mixture of glycosaminoglycans.
Cosmi B; Cini M; Legnani C; Pancani C; Calanni F; Coccheri S
Thromb Res; 2003 Mar; 109(5-6):333-9. PubMed ID: 12818259
[TBL] [Abstract][Full Text] [Related]
14. Comparison of hemostatic disturbances between patients on CAPD and patients on hemodialysis.
Malyszko J; Malyszko JS; Mysliwiec M
Perit Dial Int; 2001; 21(2):158-65. PubMed ID: 11330560
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular risk factors in diabetic patients undergoing continuous ambulatory peritoneal dialysis.
Babazono T; Miyamae M; Tomonaga O; Omori Y
Adv Perit Dial; 1996; 12():120-5. PubMed ID: 8865885
[TBL] [Abstract][Full Text] [Related]
16. Review of pharmacodynamics, pharmacokinetics, and therapeutic properties of sulodexide.
Harenberg J
Med Res Rev; 1998 Jan; 18(1):1-20. PubMed ID: 9436179
[TBL] [Abstract][Full Text] [Related]
17. [Method of dialysis therapy and selected markers of oxidative stress and endothelial injury in patients with chronic renal failure].
Pawlak K; Pawlak D; Myśliwiec M
Pol Arch Med Wewn; 2005 Jan; 113(1):21-6. PubMed ID: 16130597
[TBL] [Abstract][Full Text] [Related]
18. Effects of celecoxib on high-sensitivity C-reactive protein in chronic peritoneal dialysis patients.
Kim SB; Kim SH; Chang JW; Lee SK; Min WK; Chi HS; Park JS
Ren Fail; 2004 Jul; 26(4):381-4. PubMed ID: 15462105
[TBL] [Abstract][Full Text] [Related]
19. Cytokines, adipocytokines and inflammatory markers in patients on continuous ambulatory peritoneal dialysis and hemodialysis.
Oncel M; Akbulut S; Toka Ozer T; Kiyici A; Keles M; Baltaci B; Turk S
Ren Fail; 2016 Aug; 38(7):1071-5. PubMed ID: 27267129
[TBL] [Abstract][Full Text] [Related]
20. Effects of gemfibrozil on lipid and hemostatic factors in CAPD patients.
Lee MS; Kim SM; Kim SB; Lee SK; Park JS; Yang WS
Perit Dial Int; 1999; 19(3):280-3. PubMed ID: 10433170
[No Abstract] [Full Text] [Related]
[Next] [New Search]
